Skip to main content
Clinical Trials/NCT03465189
NCT03465189
Completed
Not Applicable

Validation of a Seizure Monitoring System

St Vincent's Hospital Melbourne1 site in 1 country10 target enrollmentSeptember 10, 2018
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
St Vincent's Hospital Melbourne
Enrollment
10
Locations
1
Primary Endpoint
Verify feasibility of using the LINQ device for epilepsy diagnosis, monitoring and management
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.

Registry
clinicaltrials.gov
Start Date
September 10, 2018
End Date
March 19, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
St Vincent's Hospital Melbourne
Responsible Party
Principal Investigator
Principal Investigator

Mark Cook

Principal Investigator

St Vincent's Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Patients with epilepsy

Exclusion Criteria

  • Women that are pregnant
  • Patients that are highly dependant on medical care
  • Patients that cannot give informed consent for themselves

Outcomes

Primary Outcomes

Verify feasibility of using the LINQ device for epilepsy diagnosis, monitoring and management

Time Frame: one week

Compare EEG from traditional scalp EEG to the LINQ recordings to determine if seizure activity can be accurately identified

Study Sites (1)

Loading locations...

Similar Trials